BioSpace News Archive

Freeline, a biotechnology company focused on developing curative gene therapy for chronic systemic diseases, today announces a new program for Gaucher Disease, an inherited metabolic disorder characterized by the progressive build-up of glucocerebroside in lysosomes throughout the body

The Asia Pacific Medical Technology Association today announced the appointment of its new Chief Executive Officer, Ms Harjit Gill, a recognised healthcare leader in the region with more than 25 years of experience in health and consumer technology products spanning Asia, Europe and the Middle East.

Stand Together, a national venture philanthropy group and social change organization dedicated to breaking the cycle of poverty, today reported a total of $30.6 million in investments throughout the month of January, during National Poverty Awareness Month.

Novartis today announced that Kymriah® (tisagenlecleucel) treatment for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments is to be made available for NHS patients in England and Wales following appraisal by NICE (National Institute for Health and Care Excellence).

Genetic testing improves the diagnoses of abnormalities in developing babies that are picked up during ultrasound scans, scientists report today (31 January) in The Lancet.

The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.

Cresco Labs (CSE: CL) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced that the Company’s FloraMedex dispensary launched Illinois’ Opioid Alternative Pilot Program (OAPP) today vastly expanding the population of Illinois patients who can access medical cannabis in place of pharmaceutical opioid medications.

Patient safety advocates testified to the Medical Board of California that its initiative to investigate excessive prescribing by doctors involved in prescription overdose deaths is critical to state efforts to end the opioid overdose epidemic.

A retrospective analysis – reported in the journal Breast Cancer Research and Treatment, by Judith Malmgren, PhD, and co-authors – studied 8292 women with stage I-III invasive breast cancer, 964 of whom were later diagnosed with recurrent metastatic breast cancer.

The American Society for Blood and Marrow Transplantation (ASBMT) released a paper on chimeric antigen receptor T cell therapy that proposes a new consensus grading scale for toxicities to be applied across clinical trials, academic research and commercial product development.